124 related articles for article (PubMed ID: 20164435)
21. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
Keech CL; Pang KC; McCluskey J; Chen W
Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
[TBL] [Abstract][Full Text] [Related]
22. Effect of gamma radiation on resting B lymphocytes. II. Functional characterization of the antigen-presentation defect.
Ashwell JD; Jenkins MK; Schwartz RH
J Immunol; 1988 Oct; 141(8):2536-44. PubMed ID: 2844902
[TBL] [Abstract][Full Text] [Related]
23. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
24. Characterization of antigen processing and presentation by resting B lymphocytes.
Gosselin EJ; Tony HP; Parker DC
J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
[TBL] [Abstract][Full Text] [Related]
25. Receptor-mediated B cell antigen processing. Increased antigenicity of a globular protein covalently coupled to antibodies specific for B cell surface structures.
Casten LA; Pierce SK
J Immunol; 1988 Jan; 140(2):404-10. PubMed ID: 2447176
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
27. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs.
Ozaki ME; Coren BA; Huynh TN; Redondo DJ; Kikutani H; Webb SR
J Immunol; 1999 Nov; 163(10):5250-6. PubMed ID: 10553046
[TBL] [Abstract][Full Text] [Related]
29. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.
Corinti S; Medaglini D; Cavani A; Rescigno M; Pozzi G; Ricciardi-Castagnoli P; Girolomoni G
J Immunol; 1999 Sep; 163(6):3029-36. PubMed ID: 10477566
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells in germ-free and specific pathogen-free mice have similar phenotypes and in vitro antigen presenting function.
Walton KL; He J; Kelsall BL; Sartor RB; Fisher NC
Immunol Lett; 2006 Jan; 102(1):16-24. PubMed ID: 16105690
[TBL] [Abstract][Full Text] [Related]
31. A matter of timing: unsynchronized antigen expression and antigen presentation diminish secondary T cell responses.
Elnekave M; Bivas-Benita M; Gillard GO; Sircar P; Hovav AH
J Immunol; 2009 Jul; 183(2):1013-21. PubMed ID: 19561108
[TBL] [Abstract][Full Text] [Related]
32. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
33. Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue.
Reis e Sousa C; Germain RN
J Immunol; 1999 Jun; 162(11):6552-61. PubMed ID: 10352271
[TBL] [Abstract][Full Text] [Related]
34. Presence of activated antigen-binding B cells during immunization enhances relative levels of IFN-gamma in T cell responses.
Pasare C; Morafo V; Entringer M; Bansal P; George A; Bal V; Rath S; Durdik JM
J Immunol; 1998 Jan; 160(2):778-87. PubMed ID: 9551913
[TBL] [Abstract][Full Text] [Related]
35. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
37. Time dependence of B cell processing and presentation of peptide and native protein antigens.
Lakey EK; Casten LA; Niebling WL; Margoliash E; Pierce SK
J Immunol; 1988 May; 140(10):3309-14. PubMed ID: 2834435
[TBL] [Abstract][Full Text] [Related]
38. Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
Hewitt EW; Treumann A; Morrice N; Tatnell PJ; Kay J; Watts C
J Immunol; 1997 Nov; 159(10):4693-9. PubMed ID: 9366392
[TBL] [Abstract][Full Text] [Related]
39. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
[TBL] [Abstract][Full Text] [Related]
40. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
Manoury B; Gregory WF; Maizels RM; Watts C
Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
